Anti-Amyloid Drugs
Cross-source consensus on Anti-Amyloid Drugs from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Risks & contraindications
Evidence quality
Other
Highlighted claims
- Aducanumab and lecanemab are monoclonal antibodies that reduce amyloid plaques. — Dementia Prevention, the Amyloid Fraud, and Brain Health Optimization
- The drugs received accelerated FDA approval despite no clinically meaningful improvement in Alzheimer's symptoms, according to the article. — Dementia Prevention, the Amyloid Fraud, and Brain Health Optimization
- The drugs cost about $28,000 per year. — Dementia Prevention, the Amyloid Fraud, and Brain Health Optimization
- The article lists brain swelling, brain bleeding, and death in some patients as side effects of anti-amyloid drugs. — Dementia Prevention, the Amyloid Fraud, and Brain Health Optimization
- A meta-analysis is described as finding that these drugs increase the speed of brain atrophy. — Dementia Prevention, the Amyloid Fraud, and Brain Health Optimization